Neuroblastoma origin and therapeutic targets for immunotherapy

IV Kholodenko, DV Kalinovsky… - Journal of …, 2018 - Wiley Online Library
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique
features of this type of cancer frequently hamper the process of determining clinical …

Ovarian cancer stem cells and targeted therapy

V Keyvani, M Farshchian, SA Esmaeili, H Yari… - Journal of ovarian …, 2019 - Springer
Background Ovarian cancer has the highest ratio of mortality among gynecologic
malignancies. Chemotherapy is one of the most common treatment options for ovarian …

[HTML][HTML] Tumoral heterogeneity in neuroblastoma

RL Gomez, S Ibragimova, R Ramachandran… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Neuroblastoma is a solid, neuroendocrine tumor with divergent clinical behavior ranging
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …

Cancer stem cells in neuroblastoma: expanding the therapeutic frontier

HF Bahmad, F Chamaa, S Assi… - Frontiers in molecular …, 2019 - frontiersin.org
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in
childhood. Despite intense efforts to develop a successful treatment, current available …

Strategies for isolating and enriching cancer stem cells: well begun is half done

J Duan, W Qiu, S Xu, B Wang, X Ye, Y **… - Stem cells and …, 2013 - liebertpub.com
Cancer stem cells (CSCs) constitute a subpopulation of cancer cells that have the potential
for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and …

[HTML][HTML] Ovarian cancer and cancer stem cells—cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and …

A Nowicki, M Kulus, M Wieczorkiewicz, W Pieńkowski… - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer is still a high-risk, metastatic disease, often diagnosed at a
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …

ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder

H Keymoosi, E Gheytanchi, M Asgari… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is one of the
promising markers for identifying cancer stem cells in many cancer types, along with other …

The dual HDAC and PI3K inhibitor, CUDC-907, inhibits tumor growth and stem-like properties by suppressing PTX3 in neuroblastoma

M Li, Y Hu, J Wang, Y Xu, Y Hong… - International …, 2023 - spandidos-publications.com
Neuroblastoma (NB) is one of the common solid tumors in childhood and poses a threat to
the lives of children. Patients with advanced-stage or recurrent NB have a poor prognosis …

Co-expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas

E Kalantari, M Asgari, S Nikpanah, N Salarieh… - Pathology & Oncology …, 2017 - Springer
Cancer stem cells (CSCs) are the main players of prostate tumorigenesis thus;
characterization of CSCs can pave the way for understanding the early detection, drug …

Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells

A Babajani, A Eftekharinasab, S Bekeschus… - Cancer Cell …, 2024 - Springer
Cancer remains a major global health challenge, with the persistence of cancer stem cells
(CSCs) contributing to treatment resistance and relapse. Despite advancements in cancer …